The Curbsiders Internal Medicine Podcast

#347 USPSTF Update: Aspirin for Primary Prevention of CVD

Jul 27, 2022
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Aspernuss for Primary a Cardiovascular Disease Prevention - Dr John Wong
01:52 • 2min
3
Pc F Guideline for Asperon for Primary Prevention of Cardy Vascor Disease
03:31 • 2min
4
Prevalence of Heart Disease and Stroke
05:24 • 2min
5
Is There a Pooled Cohort Risk Estimator?
07:22 • 2min
6
Aspirant for Adults Between 40 and 59?
09:02 • 2min
7
Cardiovascular Disease - The Evidence for Benefit
10:38 • 2min
8
What Happens to Aspirant for Diabedes?
12:10 • 2min
9
Cardiovascular Benefits Versus Placeb
13:58 • 2min
10
Preventing Cardiac Vascular Disease With Aspirin
15:31 • 2min
11
What Has Happened Over the Past Fourty Five Years?
17:13 • 2min
12
The New Zealand Study on Gastrointestinal Bleeding
19:15 • 2min
13
Med Mastery and Curb Siders Podcast Review
20:51 • 2min
14
Is It a Good Idea to Start Aspernus?
22:54 • 2min
15
Is There a Recommendation to Stop Aspirant?
24:31 • 2min
16
Is There a Recommendation to Stop Aspirat?
26:47 • 2min
17
Coloreto Cancer Prevention - Is There a Review of Evidence?
28:29 • 2min
18
Is There a Reduction in Coloreto Cancer Risk?
30:08 • 1min
19
The Curb Siders Podcast Review
31:34 • 3min